SOUND ENHANCEMENT FOR COCHLEAR IMPLANTS
    5.
    发明申请
    SOUND ENHANCEMENT FOR COCHLEAR IMPLANTS 审中-公开
    声音增强对于COCHLEAR IMPLANTS

    公开(公告)号:US20170043162A1

    公开(公告)日:2017-02-16

    申请号:US15303798

    申请日:2015-04-28

    Abstract: This document mainly discloses a method and a device for sound enhancement, both aspects of the invention hereby described are directed to cochlear implants. The method for sound enhancement and the sound enhancement device comprising a component adapted to carry out said method are based on processing the envelope for frequency bands of the acoustic signal captured, said amplification is directed to the gain value of the amplification according to an amplitude of an output signal of the other sound processor.

    Abstract translation: 该文献主要公开了一种用于声音增强的方法和装置,其中描述的本发明的两个方面都针对人工耳蜗。 用于声音增强的方法和包括适于执行所述方法的部件的声音增强装置基于对所捕获的声信号的频带的包络进行处理,所述放大根据幅度的幅度来指向放大的增益值 另一个声音处理器的输出信号。

    METHOD FOR THE DETECTION OF RENAL DAMAGE
    6.
    发明申请
    METHOD FOR THE DETECTION OF RENAL DAMAGE 审中-公开
    检测肾损害的方法

    公开(公告)号:US20120220480A1

    公开(公告)日:2012-08-30

    申请号:US13388506

    申请日:2010-07-19

    CPC classification number: G01N33/6893 G01N2800/347 G01N2800/50 G01N2800/60

    Abstract: The invention relates to a method for determining the presence of renal damage in an individual and also to a method for detecting one or several proteins selected from the list comprising Reg3B, fetuin B, Ras-related GTP-binding protein A serine protease inhibitor A3L, subunit 1 of COP9, gamma subunit of ATP synthase, gelsolin, ribonuclease UK114, aminoacylase 1A, alpha-enolase, keratin 5, parvalbumin alpha, ribonuclease 4 or serine protease inhibitor A3K. The renal damage may be acute renal failure. Said renal pathologies may be caused by the administration of a nephrotoxic agent, wherein the nephrotoxic agent may be an aminoglycoside antibiotic such as gentamicin, or cisplatin. The invention also provides means to differentiate the renal damage or renal failure induced by gentamicin from that induced by cisplatin, through the biochemical analysis of the urinary level of Reg3B and/or gelsolin, or fragments thereof.

    Abstract translation: 本发明涉及一种用于确定个体中肾损伤的存在的方法,还涉及用于检测选自包含Reg3B,胎球蛋白B,Ras相关GTP结合蛋白A丝氨酸蛋白酶抑制剂A3L的一种或多种蛋白质的方法, COP9的亚基1,ATP合成酶的γ亚基,凝溶胶蛋白,核糖核酸酶UK114,氨基酰化酶1A,α-烯醇化酶,角蛋白5,小白蛋白α,核糖核酸酶4或丝氨酸蛋白酶抑制剂A3K。 肾损伤可能是急性肾衰竭。 所述肾脏病变可以由施用肾毒性剂引起,其中所述肾毒性剂可以是氨基糖苷类抗生素如庆大霉素或顺铂。 本发明还提供了通过Reg3B和/或凝溶胶蛋白或其片段的尿液水平的生物化学分析来区分由庆大霉素诱导的肾损伤或肾衰竭与顺铂诱导的手段。

Patent Agency Ranking